SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
311keep in mind they hired some bankers a while back...that would be about it that mopgcw-8/23/2007
310>>CV Therapeutics Announces Eight Abstracts Accepted for Presentation at ttuck-8/22/2007
309CV Therapeutics Falls After Downgrade Tuesday July 31, 11:14 am ET Needham Analyidos-7/31/2007
308>>CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action ftuck-7/9/2007
307Cramer recommended this today as a speculative play. We shall see.....Norrin Radd-6/16/2007
306Restructuring announcement today... Message 23569393 The ML assessment in Aprilpgo-neil-5/24/2007
305>>Third Point Reports 9.9% Stake In CV Therapeutics Last update: 5/17/2007tuck-5/17/2007
304mstar: CV Therapeutics CVTX announced Monday that it has submitted regadenosonmopgcw-5/15/2007
303I'll counter your GS with a Merrill (not that it adds much) <i>Ranexatom pope-4/25/2007
302CV Therapeutics Inc: No Real Change to the Thesis MORGAN STANLE 2007-04-24 19:07mopgcw-4/25/2007
301forbes: New Drug Takes Aim At Stents Matthew Herper, 03.27.07, 11:40 AM ET NEW mopgcw-3/30/2007
300forbes: A Good Failure? Matthew Herper, 03.07.07, 6:00 AM ET Tiny biotech CV Thmopgcw-3/9/2007
299mstar: CV Therapeutics' CVTX Ranexa expansion trial results were announced mopgcw-3/8/2007
298Nice going, Tuck. You're too agreeable to say "I told you so" sokeokalani'nui-3/7/2007
297Why my wife sometimes think I'm as thick as four planks - at first read I thtom pope-3/7/2007
296CV Therapeutics Announces Topline MERLIN TIMI-36 Results Tuesday March 6, 4:01 pdr.praveen-3/6/2007
295citi: CV THERAPEUTICS (CVTX)-HOLD/SPECULATIVE (2S) As in previous quarters, themopgcw-1/25/2007
294CV Therapeutics Shares Rise on Coverage Friday January 19, 12:51 pm ET CV Thermopgcw-1/20/2007
293>>01-19-07 1619ET DJ CV Therapeutics Files $160M Common Stock Shelf >Ctuck-1/19/2007
292a good tidbit, but it hinges on angina...i am still in, basis of 12, meant to remopgcw-12/4/2006
291>>Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial Mondtuck-12/4/2006
290Item 8.01. Other Events In October and November 2006, CV Therapeutics reached pmopgcw-11/3/2006
289CV Therapeutics Posts Wider 3rd-Quarter Loss As Doctors Balk at Prescribing Ranemopgcw-11/3/2006
288CV Therapeutics Reports 2006 Third Quarter Financial Results Tuesday October 31,mopgcw-11/3/2006
287Waiting for CVT's Trial Results By Brian Lawler November 1, 2006 Biopharmmopgcw-11/3/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News